GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that its wholly-owned subsidiaries, Beijing GP Medical Technologies Co., Ltd. ("GP Medical") and Beijing Yuande Bio-Medical Engineering Co., Ltd. ("Beijing Yuande"), have been ranked 12th and 415th, respectively, in the Deloitte Technology Fast 500 Asia Pacific 2010 program. GP Medical operates the fast growing molecular diagnostic business of the Company, and Beijing Yuande operates the immunodiagnostic business of the Company.

"We are honored to be named in the Deloitte Technology Fast 500 Asia Pacific for 2010," commented Mr. Xiaodong Wu, Chairman and Chief Executive Officer of the Company. "We believe that there is good market potential in both molecular diagnostics and immunodiagnostics in China, and we will continue to focus on capturing these market opportunities."